Haleon | 6-K: Notice Of Annual General Meeting
Apr 12 07:51 ET
Haleon | 6-K: Notification And Public Disclosure Of Transactions By Persons Discharging Managerial Responsibilities And Their Closely Associated Persons
Apr 3 07:27 ET
Haleon | 6-K: Total Voting Rights and Capital
Apr 2 09:24 ET
Haleon | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 25 10:48 ET
Haleon | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)
Mar 22 09:07 ET
Haleon | 6-K: Disclosure of Holding(S) of Voting Rights in Company
Mar 22 08:07 ET
Haleon | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 21 13:51 ET
Haleon | 6-K: Haleon Announces Cancellation of Repurchased Common Shares
Mar 21 13:51 ET
Haleon | 6-K: Buyback Of £315m Of Pfizer Ordinary Shares In Secondary Global Offering
Mar 21 13:26 ET
Haleon | 6-K: Prospectus Supplement of Haleon
Mar 20 09:02 ET
Haleon | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(32.0%)
Mar 19 20:53 ET
Haleon | 424B1: Prospectus
Mar 19 16:53 ET
Haleon | 6-K: Haleon Plc To Expand Repurchase Of Ordinary Shares From Pfizer In Secondary Global Offering Pricing
Mar 19 06:06 ET
Haleon | 6-K: Prospectus Supplement of Haleon
Mar 18 11:00 ET
Haleon | 6-K: Haleon plc: Proposed Secondary Global Offering by Pfizer Inc. in Haleon plc and Proposed Share Buyback
Mar 18 10:24 ET
Haleon | 424B1: Prospectus
Mar 18 06:34 ET
Haleon | 6-K: Entered Into A Share Repurchase Agreement
Mar 18 06:09 ET
Haleon | 6-K: Consent of Independent Registered Public Accounting Firm
Mar 18 06:09 ET
Haleon | 6-K: Haleon Releases 2023 Annual Report and Form 20-F
Mar 15 13:06 ET
Haleon | 20-F: Registration statement / Annual report / Transition report
Mar 15 11:20 ET
No Data
No Data